Biomarin Pharmaceutical Inc (BMRN) — Defensive Interval Ratio
Biomarin Pharmaceutical Inc (BMRN) has a Defensive Interval Ratio of 233 days as of June 2026. Defensive assets of $1.06 Billion (cash $-, short-term investments $0.00, receivables $1.06 Billion) cover 233 days of daily cash needs of $4.56 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Biomarin Pharmaceutical Inc Defensive Interval Ratio (1998–2025)
This chart shows how Biomarin Pharmaceutical Inc's Defensive Interval Ratio has evolved across 28 annual periods from 1998 to 2025. As of June 2026, the ratio stands at 233 days, meaning defensive assets of $1.06 Billion can fund 233 days of operations without new revenue. For the complete balance sheet picture, see BMRN current and non-current assets.
Annual Defensive Interval Ratio for Biomarin Pharmaceutical Inc (1998–2025)
The table below presents the year-by-year Defensive Interval Ratio for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 28 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Biomarin Pharmaceutical Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 556 days | $1.16 Billion | $2.08 Million/day | $- | $248.93 Million | ▲ +42 days |
| 2024 | 514 days | $855.40 Million | $1.66 Million/day | $- | $194.86 Million | ▲ +219 days |
| 2023 | 295 days | $952.39 Million | $3.22 Million/day | $- | $318.68 Million | ▼ -342 days |
| 2022 | 637 days | $1.03 Billion | $1.61 Million/day | $- | $567.01 Million | ▲ +96 days |
| 2021 | 541 days | $800.00 Million | $1.48 Million/day | $- | $426.60 Million | ▼ -100 days |
| 2020 | 641 days | $864.58 Million | $1.35 Million/day | $- | $416.23 Million | ▲ +369 days |
| 2019 | 272 days | $693.76 Million | $2.55 Million/day | $- | $316.36 Million | ▼ -379 days |
| 2018 | 651 days | $932.96 Million | $1.43 Million/day | $- | $590.33 Million | ▲ +177 days |
| 2017 | 474 days | $1.06 Billion | $2.24 Million/day | $- | $797.94 Million | ▼ -22 days |
| 2016 | 496 days | $596.63 Million | $1.20 Million/day | $- | $381.35 Million | ▲ +200 days |
| 2015 | 295 days | $360.54 Million | $1.22 Million/day | $- | $195.58 Million | ▼ -36 days |
| 2014 | 332 days | $214.18 Million | $645.86K/day | $- | $69.71 Million | ▼ -356 days |
| 2013 | 688 days | $345.28 Million | $502.11K/day | $- | $215.94 Million | ▼ -125 days |
| 2012 | 812 days | $379.28 Million | $466.94K/day | $- | $270.21 Million | ▼ -213 days |
| 2011 | 1026 days | $264.46 Million | $257.88K/day | $- | $148.82 Million | ▼ -161 days |
| 2010 | 1187 days | $272.61 Million | $229.71K/day | $- | $186.03 Million | ▲ +187 days |
| 2009 | 1000 days | $214.13 Million | $214.12K/day | $- | $133.51 Million | ▼ -98 days |
| 2008 | 1098 days | $391.19 Million | $356.39K/day | $- | $336.89 Million | ▼ -1122 days |
| 2007 | 2219 days | $374.23 Million | $168.61K/day | $- | $357.25 Million | ▲ +520 days |
| 2006 | 1699 days | $214.35 Million | $126.15K/day | $- | $199.69 Million | ▲ +1549 days |
| 2005 | 150 days | $16.63 Million | $110.59K/day | $- | $9.70 Million | ▼ -57 days |
| 2004 | 207 days | $39.78 Million | $191.93K/day | $- | $35.73 Million | ▼ -2212 days |
| 2003 | 2420 days | $84.95 Million | $35.11K/day | $- | $84.95 Million | ▲ +269 days |
| 2002 | 2150 days | $40.34 Million | $18.76K/day | $- | $40.34 Million | ▼ -3199 days |
| 2001 | 5349 days | $121.67 Million | $22.75K/day | $- | $118.57 Million | ▲ +3938 days |
| 2000 | 1411 days | $26.61 Million | $18.86K/day | $- | $23.67 Million | ▼ -1606 days |
| 1999 | 3016 days | $42.04 Million | $13.94K/day | $- | $39.57 Million | ▲ +2889 days |
| 1998 | 128 days | $700.00K | $5.48K/day | $- | $- | — |